EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020639
Gene Symbol: TAAR1
1 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020628
Gene Symbol: TAAR1
2 Cross references
399 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020623
Gene Symbol: TAAR1
3 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020615
Gene Symbol: TAAR1
2 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020610
Gene Symbol: TAAR1
1 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020603
Gene Symbol: TAAR1
2 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020588
Gene Symbol: TAAR1
4 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020576
Gene Symbol: TAAR1
1 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020534
Gene Symbol: TAAR1
1 Cross references
392 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000020569
Gene Symbol: TAAR1
3 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000019106
Gene Symbol: TAAR1
3 Cross references
415 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSKMAG00000019116
Gene Symbol: TAAR1
1 Cross references
346 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).